vs
百胜餐饮集团(LCUT)与Tarsus Pharmaceuticals, Inc.(TARS)财务数据对比。点击上方公司名可切换其他公司
百胜餐饮集团的季度营收约是Tarsus Pharmaceuticals, Inc.的1.3倍($204.1M vs $151.7M),百胜餐饮集团净利率更高(8.9% vs -5.5%,领先14.4%),Tarsus Pharmaceuticals, Inc.同比增速更快(128.4% vs -5.2%),Tarsus Pharmaceuticals, Inc.自由现金流更多($13.0M vs $2.6M),过去两年Tarsus Pharmaceuticals, Inc.的营收复合增速更高(134.4% vs 19.8%)
百胜餐饮集团是美国跨国快餐企业,1977年百事可乐收购肯德基、必胜客、塔可Bell后将其整合为旗下子公司,1997年百事剥离该业务板块后正式独立为百胜集团。集团目前运营肯德基、必胜客、塔可Bell、哈比特汉堡等多个餐饮品牌,同时布局相关餐饮科技业务,门店网络遍布全球多个国家和地区。
Tarsus Pharmaceuticals是一家处于后期临床阶段的生物制药公司,专注于眼科、皮肤科等专科领域创新疗法的研发和商业化,主打产品针对蠕形螨睑缘炎、玫瑰痤疮等未被充分诊断的常见病症,核心市场为美国。
LCUT vs TARS — 直观对比
营收规模更大
LCUT
是对方的1.3倍
$151.7M
营收增速更快
TARS
高出133.6%
-5.2%
净利率更高
LCUT
高出14.4%
-5.5%
自由现金流更多
TARS
多$10.4M
$2.6M
两年增速更快
TARS
近两年复合增速
19.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $204.1M | $151.7M |
| 净利润 | $18.2M | $-8.4M |
| 毛利率 | 38.6% | — |
| 营业利润率 | 9.8% | -5.3% |
| 净利率 | 8.9% | -5.5% |
| 营收同比 | -5.2% | 128.4% |
| 净利润同比 | 103.5% | 63.8% |
| 每股收益(稀释后) | $0.83 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
LCUT
TARS
| Q4 25 | $204.1M | $151.7M | ||
| Q3 25 | $171.9M | $118.7M | ||
| Q2 25 | $131.9M | $102.7M | ||
| Q1 25 | $140.1M | $78.3M | ||
| Q4 24 | $215.2M | $66.4M | ||
| Q3 24 | $183.8M | $48.1M | ||
| Q2 24 | $141.7M | $40.8M | ||
| Q1 24 | $142.2M | $27.6M |
净利润
LCUT
TARS
| Q4 25 | $18.2M | $-8.4M | ||
| Q3 25 | $-1.2M | $-12.6M | ||
| Q2 25 | $-39.7M | $-20.3M | ||
| Q1 25 | $-4.2M | $-25.1M | ||
| Q4 24 | $8.9M | $-23.1M | ||
| Q3 24 | $344.0K | $-23.4M | ||
| Q2 24 | $-18.2M | $-33.3M | ||
| Q1 24 | $-6.3M | $-35.7M |
毛利率
LCUT
TARS
| Q4 25 | 38.6% | — | ||
| Q3 25 | 35.1% | — | ||
| Q2 25 | 38.6% | — | ||
| Q1 25 | 36.1% | — | ||
| Q4 24 | 37.7% | — | ||
| Q3 24 | 36.7% | — | ||
| Q2 24 | 38.5% | — | ||
| Q1 24 | 40.5% | — |
营业利润率
LCUT
TARS
| Q4 25 | 9.8% | -5.3% | ||
| Q3 25 | 3.9% | -12.2% | ||
| Q2 25 | -28.2% | -21.6% | ||
| Q1 25 | 0.8% | -33.5% | ||
| Q4 24 | 7.2% | -36.8% | ||
| Q3 24 | 4.7% | -52.3% | ||
| Q2 24 | 0.8% | -81.6% | ||
| Q1 24 | 1.3% | -136.5% |
净利率
LCUT
TARS
| Q4 25 | 8.9% | -5.5% | ||
| Q3 25 | -0.7% | -10.6% | ||
| Q2 25 | -30.1% | -19.8% | ||
| Q1 25 | -3.0% | -32.1% | ||
| Q4 24 | 4.1% | -34.8% | ||
| Q3 24 | 0.2% | -48.7% | ||
| Q2 24 | -12.8% | -81.6% | ||
| Q1 24 | -4.4% | -129.4% |
每股收益(稀释后)
LCUT
TARS
| Q4 25 | $0.83 | $-0.17 | ||
| Q3 25 | $-0.05 | $-0.30 | ||
| Q2 25 | $-1.83 | $-0.48 | ||
| Q1 25 | $-0.19 | $-0.64 | ||
| Q4 24 | $0.41 | $-0.57 | ||
| Q3 24 | $0.02 | $-0.61 | ||
| Q2 24 | $-0.85 | $-0.88 | ||
| Q1 24 | $-0.29 | $-1.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $4.3M | $417.3M |
| 总债务越低越好 | $135.0M | $72.4M |
| 股东权益账面价值 | $202.3M | $343.4M |
| 总资产 | $572.6M | $562.2M |
| 负债/权益比越低杠杆越低 | 0.67× | 0.21× |
8季度趋势,按日历期对齐
现金及短期投资
LCUT
TARS
| Q4 25 | $4.3M | $417.3M | ||
| Q3 25 | $12.1M | $401.8M | ||
| Q2 25 | $12.0M | $381.1M | ||
| Q1 25 | $10.4M | $407.9M | ||
| Q4 24 | $2.9M | $291.4M | ||
| Q3 24 | $6.0M | $317.0M | ||
| Q2 24 | $3.4M | $323.6M | ||
| Q1 24 | $4.6M | $298.5M |
总债务
LCUT
TARS
| Q4 25 | $135.0M | $72.4M | ||
| Q3 25 | — | $72.3M | ||
| Q2 25 | — | $72.1M | ||
| Q1 25 | — | $72.0M | ||
| Q4 24 | $142.5M | $71.8M | ||
| Q3 24 | — | $71.7M | ||
| Q2 24 | — | $71.6M | ||
| Q1 24 | — | $29.9M |
股东权益
LCUT
TARS
| Q4 25 | $202.3M | $343.4M | ||
| Q3 25 | $184.6M | $335.1M | ||
| Q2 25 | $185.8M | $332.6M | ||
| Q1 25 | $225.7M | $342.5M | ||
| Q4 24 | $229.9M | $224.5M | ||
| Q3 24 | $220.9M | $237.5M | ||
| Q2 24 | $219.8M | $252.2M | ||
| Q1 24 | $223.7M | $275.2M |
总资产
LCUT
TARS
| Q4 25 | $572.6M | $562.2M | ||
| Q3 25 | $581.1M | $534.6M | ||
| Q2 25 | $551.9M | $495.0M | ||
| Q1 25 | $594.6M | $500.8M | ||
| Q4 24 | $634.3M | $377.0M | ||
| Q3 24 | $668.7M | $376.3M | ||
| Q2 24 | $617.0M | $376.8M | ||
| Q1 24 | $602.7M | $349.3M |
负债/权益比
LCUT
TARS
| Q4 25 | 0.67× | 0.21× | ||
| Q3 25 | — | 0.22× | ||
| Q2 25 | — | 0.22× | ||
| Q1 25 | — | 0.21× | ||
| Q4 24 | 0.62× | 0.32× | ||
| Q3 24 | — | 0.30× | ||
| Q2 24 | — | 0.28× | ||
| Q1 24 | — | 0.11× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $3.7M | $19.3M |
| 自由现金流经营现金流 - 资本支出 | $2.6M | $13.0M |
| 自由现金流率自由现金流/营收 | 1.3% | 8.6% |
| 资本支出强度资本支出/营收 | 0.6% | 4.2% |
| 现金转化率经营现金流/净利润 | 0.21× | — |
| 过去12个月自由现金流最近4个季度 | $3.3M | $-22.3M |
8季度趋势,按日历期对齐
经营现金流
LCUT
TARS
| Q4 25 | $3.7M | $19.3M | ||
| Q3 25 | $-22.2M | $18.3M | ||
| Q2 25 | $9.3M | $-29.4M | ||
| Q1 25 | $16.7M | $-20.7M | ||
| Q4 24 | $20.3M | $-22.2M | ||
| Q3 24 | $-22.7M | $-8.7M | ||
| Q2 24 | $10.4M | $-14.4M | ||
| Q1 24 | $10.5M | $-37.8M |
自由现金流
LCUT
TARS
| Q4 25 | $2.6M | $13.0M | ||
| Q3 25 | $-22.7M | $16.3M | ||
| Q2 25 | $8.2M | $-30.4M | ||
| Q1 25 | $15.1M | $-21.2M | ||
| Q4 24 | $19.7M | $-22.3M | ||
| Q3 24 | $-23.2M | $-8.9M | ||
| Q2 24 | $9.9M | $-15.4M | ||
| Q1 24 | $9.9M | $-38.0M |
自由现金流率
LCUT
TARS
| Q4 25 | 1.3% | 8.6% | ||
| Q3 25 | -13.2% | 13.8% | ||
| Q2 25 | 6.2% | -29.6% | ||
| Q1 25 | 10.8% | -27.1% | ||
| Q4 24 | 9.1% | -33.5% | ||
| Q3 24 | -12.6% | -18.6% | ||
| Q2 24 | 7.0% | -37.8% | ||
| Q1 24 | 7.0% | -137.5% |
资本支出强度
LCUT
TARS
| Q4 25 | 0.6% | 4.2% | ||
| Q3 25 | 0.3% | 1.6% | ||
| Q2 25 | 0.9% | 1.0% | ||
| Q1 25 | 1.1% | 0.8% | ||
| Q4 24 | 0.3% | 0.1% | ||
| Q3 24 | 0.3% | 0.6% | ||
| Q2 24 | 0.4% | 2.5% | ||
| Q1 24 | 0.4% | 0.6% |
现金转化率
LCUT
TARS
| Q4 25 | 0.21× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.28× | — | ||
| Q3 24 | -65.89× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LCUT
| Kitchenware | $114.3M | 56% |
| Tableware | $41.7M | 20% |
| Home Solutions | $29.4M | 14% |
| Other | $18.8M | 9% |
TARS
暂无分部数据